Zap70m1Btlr/Zap70m1Btlr
involves: C57BL/6J
|
abnormal class switch recombination |
J:185495
|
abnormal humoral immune response |
J:167119
|
absent CD4-positive, alpha-beta T cells |
J:167119
|
absent CD8-positive, alpha-beta T cells |
J:167119
|
decreased IgG level |
J:185495
|
decreased T cell number |
J:185495
|
normal
immune system phenotype |
J:167119,
J:185495
|
Zap70m1Saka/Zap70+
involves: BALB/c
|
no abnormal phenotype detected |
J:86607
|
Zap70m1Saka/Zap70m1Saka
involves: BALB/c
|
abnormal lymph node cell ratio |
J:154166
|
abnormal positive T cell selection |
J:86607,
J:154166
|
abnormal splenic cell ratio |
J:154166
|
abnormal T cell clonal deletion |
J:154166
|
abnormal T cell differentiation |
J:86607
|
abnormal T cell selection |
J:86607
|
abnormal thymocyte activation |
J:154166
|
abnormal thymus cell ratio |
J:154166
|
chronic joint inflammation |
J:86607
|
decreased CD4-positive, alpha-beta T cell number |
J:86607,
J:154166
|
decreased CD8-positive, alpha-beta T cell number |
J:86607,
J:154166
|
decreased interleukin-2 secretion |
J:154166
|
decreased regulatory T cell number |
J:154166
|
decreased T cell proliferation |
J:86607,
J:154166
|
fused joints |
J:86607
|
increased activated T cell number |
J:154166
|
increased autoantibody level |
J:86607
|
increased B cell number |
J:86607
|
increased immunoglobulin level |
J:86607
|
increased interleukin-17 secretion |
J:154166
|
increased memory T cell number |
J:154166
|
increased susceptibility to induced arthritis |
J:154166
|
joint dislocation |
J:86607
|
joint swelling |
J:86607
|
lung inflammation |
J:86607
|
mixed cellular infiltration to dermis |
J:86607
|
osteoporosis |
J:86607
|
rheumatoid arthritis |
J:86607
|
Zap70m1Saka/Zap70tm1Dlo
involves: 129P2/OlaHsd * BALB/c
|
arthritis |
J:86607
|
Zap70m1Saka/Zap70tm2.1Weis
involves: 129S4/SvJae * BALB/c
|
abnormal T cell clonal deletion |
J:154166
|
decreased susceptibility to induced arthritis |
J:154166
|
Zap70m2Btlr/Zap70m2Btlr
involves: C57BL/6J
|
decreased T cell number |
J:174837
|
Zap70m3Btlr/Zap70m3Btlr
C57BL/6J-Zap70m3Btlr
|
decreased IgG level |
J:225043
|
impaired humoral immune response |
J:225043
|
Zap70m4Btlr/Zap70m4Btlr
C57BL/6J-Zap70m4Btlr
|
decreased CD4-positive, alpha-beta T cell number |
J:236698
|
decreased CD8-positive, alpha-beta T cell number |
J:236698
|
decreased T cell number |
J:236698
|
impaired hematopoiesis |
J:236698
|
Zap70m5Btlr/Zap70m5Btlr
C57BL/6J-Zap70m5Btlr
|
abnormal humoral immune response |
J:254830
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number |
J:254830
|
decreased CD8-positive, alpha-beta T cell number |
J:254830
|
decreased CD8-positive, naive alpha-beta T cell number |
J:254830
|
decreased IgG level |
J:254830
|
increased B cell number |
J:254830
|
increased central memory CD4-positive, alpha-beta T cell number |
J:254830
|
increased central memory CD8 positive, alpha-beta T cell number |
J:254830
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:254830
|
Zap70m6Btlr/Zap70m6Btlr
C57BL/6J-Zap70m6Btlr
|
abnormal humoral immune response |
J:254831
|
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number |
J:254831
|
decreased CD8-positive, alpha-beta T cell number |
J:254831
|
decreased CD8-positive, naive alpha-beta T cell number |
J:254831
|
decreased IgG level |
J:254831
|
increased B cell number |
J:254831
|
increased central memory CD4-positive, alpha-beta T cell number |
J:254831
|
increased central memory CD8 positive, alpha-beta T cell number |
J:254831
|
increased effector memory CD4-positive, alpha-beta T cell number |
J:254831
|
Zap70m6Hefl/Zap70m6Hefl
C3HeB/FeJ-Zap70m6Hefl
|
abnormal humoral immune response |
J:137446
|
abnormal T cell differentiation |
J:137446
|
decreased CD4-positive, alpha-beta T cell number |
J:137446
|
decreased CD8-positive, alpha-beta T cell number |
J:137446
|
decreased T cell number |
J:137446
|
normal
immune system phenotype |
J:137446
|
increased IgE level |
J:137446
|
increased IgG1 level |
J:137446
|
Zap70m6Hefl/Zap70tm1Weis
involves: 129X1/SvJ * C3HeB/FeJ * C57BL/10 * DBA/2
|
decreased T cell number |
J:137446
|
increased IgE level |
J:137446
|
Zap70m7Btlr/Zap70m7Btlr
C57BL/6J-Zap70m7Btlr
|
abnormal humoral immune response |
J:254832
|
decreased IgG level |
J:254832
|
increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number |
J:254832
|
increased central memory CD8 positive, alpha-beta T cell number |
J:254832
|
Zap70m8Btlr/Zap70m8Btlr
C57BL/6J-Zap70m8Btlr
|
decreased CD8-positive, naive alpha-beta T cell number |
J:272864
|
increased central memory CD8 positive, alpha-beta T cell number |
J:272864
|
Zap70mrtle/Zap70mrtle
C57BL/6JSfdAnu-Zap70mrtle/Apb
|
abnormal positive T cell selection |
J:104190
|
abnormal T cell subpopulation ratio |
J:104190
|
absent T cells |
J:104190
|
arrested T cell differentiation |
J:104190
|
decreased T cell number |
J:104190
|
Zap70mrtle/Zap70mrtle
involves: C57BL/6JSfdAnu
|
abnormal double-positive T cell morphology |
J:211510
|
abnormal regulatory T cell number |
J:211510
|
decreased CD4-positive, alpha-beta T cell number |
J:211510
|
decreased CD8-positive, alpha-beta T cell number |
J:211510
|
increased double-positive T cell number |
J:211510
|
Zap70mrtle/Zap70rps
involves: C57BL/6 * C57BL/6JSfdAnu
|
abnormal CD4-positive, alpha beta T cell morphology |
J:211510
|
abnormal double-positive T cell morphology |
J:211510
|
abnormal regulatory T cell number |
J:211510
|
decreased CD4-positive, alpha-beta T cell number |
J:211510
|
decreased CD8-positive, alpha-beta T cell number |
J:211510
|
increased double-positive T cell number |
J:211510
|
Zap70mur/Zap70mur
C57BL/6Apb-Zap70mur/ApbH
|
abnormal T cell activation |
J:104190
|
abnormal T cell physiology |
J:104190
|
decreased T cell number |
J:104190
|
increased IgG2b level |
J:104190
|
Zap70st/Zap70st
involves: C57BL/6
|
abnormal T cell physiology |
J:41170
|
arrested T cell differentiation |
J:41170
|
decreased T cell number |
J:41170
|
thymus hypoplasia |
J:41170
|
Zap70st/Zap70tm1Dlo
involves: C57BL/6
|
arrested T cell differentiation |
J:41170
|
Zap70tm1.1Mmal/Zap70tm1.1Mmal
B6.129P2-Zap70tm1.1Mmal
|
normal
immune system phenotype |
J:71099
|
Zap70tm1Dlo/Zap70tm1Dlo
involves: 129P2/OlaHsd
|
increased double-positive T cell number |
J:97610
|
Zap70tm1Weis/Zap70tm1Weis
involves: 129X1/SvJ * C57BL/6J
|
abnormal lymph node cell ratio |
J:74974
|
abnormal splenic cell ratio |
J:74974
|
abnormal T cell differentiation |
J:74974
|
arrested T cell differentiation |
J:74974
|
small lymph nodes |
J:74974
|
Zap70tm2.1Mmal/Zap70tm2.1Mmal
B6.129P2-Zap70tm2.1Mmal
|
normal
immune system phenotype |
J:71099
|
Zap70tm2.1Weis/Zap70tm2.1Weis
B6.129S4-Zap70tm2.1Weis
|
abnormal CD8-positive, alpha-beta T cell differentiation |
J:154166
|
abnormal thymus cell ratio |
J:154166
|
decreased CD4-positive, alpha-beta T cell number |
J:154166
|
decreased CD8-positive, alpha-beta T cell number |
J:154166
|
Zap70tm2.1Weis/Zap70tm2.1Weis
C.129S4-Zap70tm2.1Weis
|
abnormal lymph node cell ratio |
J:154166
|
abnormal positive T cell selection |
J:154166
|
abnormal regulatory T cell physiology |
J:154166
|
abnormal splenic cell ratio |
J:154166
|
abnormal T cell clonal deletion |
J:154166
|
abnormal thymocyte activation |
J:154166
|
abnormal thymus cell ratio |
J:154166
|
decreased CD4-positive, alpha-beta T cell number |
J:154166
|
decreased CD8-positive, alpha-beta T cell number |
J:154166
|
decreased interleukin-2 secretion |
J:154166
|
decreased regulatory T cell number |
J:154166
|
decreased T cell proliferation |
J:154166
|
normal
immune system phenotype |
J:154166
|
increased activated T cell number |
J:154166
|
increased interleukin-17 secretion |
J:154166
|
increased memory T cell number |
J:154166
|